Verkauf durch Sack Fachmedien

Newton

Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy

Medium: Buch
ISBN: 978-0-443-27356-8
Verlag: Elsevier Science
Erscheinungstermin: 01.10.2025
vorbestellbar, Erscheinungstermin ca. Oktober 2025

Handbook of Brain Tumor Chemotherapy, Molecular Therapies, and Immunotherapy, Third Edition offers a unique cutting-edge collection of basic science and clinical information brain tumor chemotherapy research. The book represents the most complete single-volume resource available for information on the subject of brain tumor chemotherapy. Including a multidisciplinary approach, this volume combines recent advances tumor therapy with molecular biology, molecular therapeutics, immunobiology, and immunotherapy approaches in one location. Chapters new to this volume include cutting-edge research on the molecular underpinnings of brain tumors such as glioblastoma, other gliomas, and targeted molecular therapies to consider for treatment.


Produkteigenschaften


  • Artikelnummer: 9780443273568
  • Medium: Buch
  • ISBN: 978-0-443-27356-8
  • Verlag: Elsevier Science
  • Erscheinungstermin: 01.10.2025
  • Sprache(n): Englisch
  • Auflage: 3rd Auflage
  • Produktform: Gebunden
  • Seiten: 848
  • Format (B x H): 216 x 276 mm
  • Ausgabetyp: Kein, Unbekannt
  • Vorauflage: 978-0-12-812100-9
Autoren/Hrsg.

Herausgeber

Herbert B. Newton, M.D., FAAN, is currently the Medical Director for the Neuro-Oncology Program and Brain Tumor Institute at the University Hospitals Cleveland Medical Center and Seidman Cancer Center, in Cleveland, Ohio, where he is also a Professor of Neurology and Solid Tumor Oncology, and holds the William Burton Risman Neurological Institute Chair in Memory and Cognition. Prior to that he was the Director of the Neuro-Oncology Center and Medical Neuro-Oncology Program at the Advent Health Cancer Institute and Advent Health Orlando Campus in Orlando, Florida. He is also retired as a Professor of Neurology and Neurosurgery, Dardinger Neuro-Oncology Center, Esther Dardinger Endowed Chair in Neuro-Oncology and Division of Neuro-Oncology at the Ohio State University Medical Center and James Cancer Hospital, in Columbus, Ohio. He is a Diplomate of the American Board of Psychiatry and Neurology, a Fellow of the American Academy of Neurology and Royal Society of Medicine, and a member of numerous national and international societies.

Section 1: PHARMACOLOGICAL AND CLINICAL APPLICATIONS
Section 2: INNOVATIVE CHEMOTHERAPY DELIVERY
Section 3: MOLECULAR BIOLOGY AND MOLECULAR THERAPEUTICS
Section 4: CHEMOTHERAPY SPECIFIC TUMORS - ADULTS
Section 5: CHEMOTHERAPY SPECIFIC TUMORS - PEDIATRICS
Section 6: IMMUNOTHERAPY FOR BRAIN TUMORS
Section 7: RESPONSE ASSESSMENT, QUALITY OF LIFE, NEUROPSYCHOLOGY, AND NEW FRONTIERS